Dr. K. Peony Yu. - 15 Jun 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Director
Issuer ticker: STAA
Reported as of: 15 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2023, 20:35:32 UTC
Prior SEC filing: 17 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Samuel Gesten as attorney-in-fact for Dr. K. Peony Yu.

Key filing fact

Dr. K. Peony Yu. filed Form 4 for STAAR SURGICAL CO (STAA) on 16 Jun 2023.

Key facts

This page summarizes Dr. K. Peony Yu.'s Form 4 filing for STAAR SURGICAL CO (STAA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2023, 20:35.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STAA transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +1,709
Change %: +159%
Price: $0.000000
Shares after: 2,786
Date: 15 Jun 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STAA transaction Derivative

Common Stock Options

Options Exercise

Transaction value: $0
Shares: +3,127
Change %
Price: $0.000000
Shares after: 3,127
Date: 15 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,127
Exercise price: $52.67
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restrictions on the 1709 restricted shares of common stock lapse on the earlier of June 15, 2023 or the Corporation's 2024 Annual Meeting, subject to Dr. Yu's continued service through that date.

Footnote F2

The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to her continued service through the vesting date.